Product Information
LANSOPRAZOL-AMOXICIL-CLARITHRO is a generic product labeled by Rising Pharma Holdings Inc., priced at $6.0422 per EA under NDC 57237000114. Its NADAC has been published 382 times since Aug 9, 2017.
Manufacturer
Rising Pharma Holdings Inc.NDC
57237000114
Classification
Generic
Dosage Form
KIT
Last Updated
11/19/2025
Approval Type
Generic (ANDA)
FDA Application
ANDA206006On Market Since
10/14/2016
Price Statistics
The NADAC for LANSOPRAZOL-AMOXICIL-CLARITHRO has been published 382 times since Aug 9, 2017, and over the history we have for it it has risen 89.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.0422 per EA |
|---|---|
| All-time high | $6.1168 (Nov 12, 2025) |
| All-time low | $2.3156 (Dec 19, 2018) |
| 52-week high | $6.1168 |
| 52-week low | $5.7126 |
| Median price | $4.6500 |
| Average price | $4.2372 |
| Largest weekly change | +62.1% (Oct 14, 2020) |
| Weeks tracked | 382 |
| Tracking since | Aug 9, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Lansoprazole, Amoxicillin, Clarithromycin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LANSOPRAZOL-AMOXICIL-CLARITHRO?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOL-AMOXICIL-CLARITHRO, manufactured by Rising Pharma Holdings Inc., is $6.0422 per EA (NDC 57237000114), effective Jun 24, 2026.
How has the price of LANSOPRAZOL-AMOXICIL-CLARITHRO changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOL-AMOXICIL-CLARITHRO has risen 89.5%. It has been tracked across 382 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOL-AMOXICIL-CLARITHRO?
Since Aug 9, 2017, the NADAC for LANSOPRAZOL-AMOXICIL-CLARITHRO has ranged from a low of $2.3156 (Dec 19, 2018) to a high of $6.1168 (Nov 12, 2025), with a median of $4.6500 per EA.
Are there cheaper alternatives to LANSOPRAZOL-AMOXICIL-CLARITHRO?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LANSOPRAZOL-AMOXICIL-CLARITHRO, so no direct lower-cost alternative is listed.
Who manufactures LANSOPRAZOL-AMOXICIL-CLARITHRO?
LANSOPRAZOL-AMOXICIL-CLARITHRO (NDC 57237000114) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification